Standout Papers

Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment 2015 2026 2018 2022 264
  1. Urine TMPRSS2:ERG Plus PCA3 for Individualized Prostate Cancer Risk Assessment (2015)
    Scott A. Tomlins, John Day et al. European Urology

Immediate Impact

1 by Nobel laureates 6 from Science/Nature 55 standout
Sub-graph 1 of 23

Citing Papers

Small and long non-coding RNAs: Past, present, and future
2024 Standout
Glycan-specific molecularly imprinted polymers towards cancer diagnostics: merits, applications, and future perspectives
2024 Standout
3 intermediate papers

Works of John Day being referenced

PCA3: A Molecular Urine Assay for Predicting Prostate Biopsy Outcome
2008
Development of a Dual Monoclonal Antibody Immunoassay for Total Human Kallikrein 2
2001
and 1 more

Author Peers

Author Last Decade Papers Cites
John Day 712 178 295 351 27 1.2k
Gary A. Pestano 482 38 293 498 41 1.0k
Larry Levy 694 111 37 164 31 1.3k
Manuel M. Morente 243 28 341 611 48 1.6k
Diane Brown 174 18 130 179 40 1.2k
Wendong Yu 221 64 171 673 40 1.2k
Wendell C. Speers 156 28 110 600 22 1.1k
Janita Lövgren 420 9 109 506 29 1.2k
Shawn Harris 135 81 507 878 13 1.3k
Christopher G. Przybycin 822 80 298 654 56 1.4k
Norman Yeh 435 51 125 207 29 1.5k

All Works

Loading papers...

Rankless by CCL
2026